Ontario’s life sciences sector contributes $58.1 billion to Ontario’s GDP, generates $8.8 billion in government revenue, and supports nearly 200,000 jobs across the province. As the engine of life sciences innovation in Canada, Ontario accounts for 51% of national life sciences R&D activity and over half of all R&D personnel…
News
TORONTO – November 19th, 2021: Life Sciences Ontario (LSO) has just launched its 4th rendition of its annual Success Stories booklet. Success Stories booklet. At LSO, we believe it’s important to broadcast the incredible success stories happening within our sector. Each year we ask organizations to submit stories showcasing how they…
LSO is deeply concerned about the PMPRB’s latest proposed changes to its Guidelines, which include an unreasonable and unexplained change to price tests and a reduction of compliance timelines for Grandfathered medicines. The proposed changes are unnecessary, inappropriate, and harmful to Canada’s life sciences ecosystem and our collective efforts to recover and…
Just in time for the fast-approaching federal election – which could be called as early as this Sunday – Life Sciences Ontario submitted two key recommendations to the federal Finance Committee for its 2022 pre-budget consultations. LSO wants the federal government to: (1) implement the Biomanufacturing and Life Sciences Strategy; and (2)…
TORONTO, June 21, 2021 –Life Sciences Ontario (LSO) and Shift Health today announced the launch of Building an Inclusive Life Sciences Future, a series of community-driven engagements and workshops aimed at mobilizing the life sciences community around a powerful vision and action plan for inclusion, diversity, equity and accessibility (IDEA). Led by…
As a quasi-judicial regulatory agency with a duty to implement government policies in a neutral and objective manner, the PMPRB’s recently released communications plan – which serves as a de facto lobbying campaign aimed at Members of Parliament and other stakeholders, and designed to counter opposing views and shore up support for its reforms…
Canada and Ontario’s life sciences sector has been leading unprecedented efforts to respond to the COVID-19 crisis. However, our sector faces an impending challenge – the planned implementation of the Government of Canada’s amendments to the Patented Medicines Regulations. These new regulations threaten to divert our sector’s attention and resources away from…
TORONTO, Ontario- May 20, 2021 – Life Sciences Ontario (LSO) has announced the launch of the document, Leading the Way Toward Recovery, Resilience and Prosperity: Roadmap for an Integrated Life Sciences Ecosystem, a follow up to the 2017 Blueprint for a Coordinated Life Sciences Strategy. Over the course of the…
Life Sciences Ontario has just launched a critical initiative to support the life sciences sector here in the province and at the national level. LSO has rallied life sciences, research and business leaders from across Canada to send an open letter to Prime Minister Trudeau, urging him to work with…
Dr. Jason Field’s separates facts from fiction in a constructive www.healthydebate.ca article (https://healthydebate.ca/opinions/failed-drug-pricing-policy/). When other countries were working collaboratively with the life sciences sector as soon as #COVID hit, Health Canada was imposing drastic and uncertain price controls. Myths are separated from facts on key issues, including How much Canadians actually spend…